Testicular Cancer – Care to Care's Clinical Criteria

Seminoma (biopsy proven)

Postdiagnostic Work Up

CT abdomen and pelvis

Brain MRI and Bone scan if clinically indicated

Post therapy Evaluation and Surveillance

Stage IA and IB Follow Up if NO Radiation Therapy

CT abdomen and pelvis

Years 1 – 3 every 3 months

Years 4 – 7 every 6 moths

Years 8 – 10 annually

Stage IA, IB and IS Follow Up after Infradiaphragmatic Radiation Therapy

CT Pelvis 3-4 months for year 1

Every 6 months year 2

Then annually for 3 yrs.

Stage IIA and IIB and III after chemotherapy

CT abdomen at 4 months

Stage IIB, IIC, III after primary chemotherapy

CT Chest, Abdomen and Pelvis

PET at about 6 weeks after completion of chemotherapy IF CT shows residual tumor

Nonseminomatous Gern Cell Tumor

Postdiagnostic Work Up

CT abdomen and pelvis

Brain MRI and Bone Scan if clinically indicated

Surveillance for stage IA and IB

Year 1 CT Abdomen every 3 months

Year 2 CT Abdomen every 4 months

Year 3 CT Abdomen every 6 months

Year 4 CT Abdomen every 6 months

Year 6+ CT Abdomen every 12 months

Surveillance after Complete Response to Chemotherapy and/or Retroperitoneal Lymph node dissection (RPLND)

Year 1 CT Abdomen/Pelvis every 3 months

Year 2 CT Abdomen/Pelvis every 6 months

Year 3+ CT Abdomen/Pelvis every 12 months

NCCN Clinical Practice Guidelines in Oncology Testicular Cancer Version 1.2012 accessed 12/28/10

NCCN Clinical Practice Guidelines in Oncology Testicular Cancer Version 2.2012 accessed 8/8/2012

NCCN Guidelines in Oncology Testicular Cancer Version 2.2012 accessed 8/8/2012